BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) has announced that its President and CEO, Kim Kelderman, will present at the 2024 Leerink Partners Healthcare Crossroads Conference.

The presentation is scheduled for May 29, 2024, at 8:40 a.m. CDT. Interested parties can access a live webcast of the presentation on Bio-Techne's Investor Relations website.

Positive

• Bio-Techne's participation in the Leerink Partners Healthcare Crossroads Conference indicates its active engagement with investors and potential stakeholders.
• The event offers an opportunity to showcase Bio-Techne's latest progress and strategic direction.

Negative

• No specific financial or strategic insights provided in the PR that could directly influence investor decisions.
• Absence of detailed information about any new products, partnerships, or financial performance metrics.

MINNEAPOLIS, May 23, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024, at 8:40 a.m. CDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at Facebook, LinkedIn, Twitter or YouTube.

About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-2024-leerink-partners-healthcare-crossroads-conference-302153744.html

SOURCE Bio-Techne Corporation

FAQ

When will Bio-Techne present at the 2024 Leerink Partners Healthcare Crossroads Conference?

Bio-Techne will present on May 29, 2024, at 8:40 a.m. CDT.

Who will represent Bio-Techne at the 2024 Leerink Partners Healthcare Crossroads Conference?

Kim Kelderman, President and CEO of Bio-Techne, will represent the company.

How can I access the live webcast of Bio-Techne's presentation at the 2024 Leerink Partners Healthcare Crossroads Conference?

The live webcast can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website.

What is the stock symbol for Bio-Techne ?

The stock symbol for Bio-Techne is TECH.